Continued">Continued">Continued">All News – Page 68 – Children Cancer Hospital Egypt 57357

All News

In a step that is not the first of its kind, the Commercial International Bank, CIB, sponsors 57357’s acquisition of the latest technology in the positron imaging field “MCT FLOW UNLIMITED” Hospital 57357 is the first in Egypt to obtain this technology that will offer more speed and precision imaging and accordingly more accurate diagnosis December 16, 2019

In a new step towards raising recovery rates and improving our services, the hospital will start utilizing the latest technology in PET-CT imaging using “MCT FLOW UNLIMITED”, the first of its kind in Egypt. The equipment is funded by CIB who have previously granted the hospital an intra operative MRI that is used in imaging … Continued

10 years during which Egypt rallied around 57357. With your support we will continue for many years to come

Today 10 years have passed since our dream, the one that all Egyptians shared in realizing, came to light 10 most challenging years during which, thanks to your support, we have established for our children the 57357 world  where  best quality care and treatment are provided free of charge 10 years during which hope in … Continued

A Protein language: deciphering the body-microbiome cross-talk December 2, 2019

A review article recently published in in the Journal of “Proteome Research”, highlights the importance of studying the “Metaprotoeme”—the total proteins produced by the community of microbes in our bodies—in providing a vivid picture of the interaction between body cells and microbiome. Microbiome is a modern term that describes the total microbes that inhabit our … Continued

Mitochondria offers a last resort for the most aggressive of breast cancers December 1, 2019

Collaborative research between Hospital 57357 and Zewail City of Science and Technology highlights the role of mitochondria in fighting breast cancer’s resistance to chemotherapy. The study titled “Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cells.”  was recently published in the  Scientific Reports, Journal on Sept, 24, … Continued

Aggresomes: A cellular indicator to predict patients’ outcomes in Pediatric Medulloblastoma November 29, 2019

Screening procedure for the presence of aggresomes could impact treatment protocols in the future In a recent study, a 57357 research team was able to detect the presence of aggresomes (aggregated protein inclusion bodies) in samples of pediatric Medulloblastoma (MB) tumors. This type of malignant brain cancer is the most common in children. The researchers were … Continued